Epicriptine
Main article: Dihydroergocryptine
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | N04BC03 (WHO) (alpha/beta) |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | beta-Dihydroergocryptine |
CAS Number | 19467-62-0 |
PubChem (CID) | 3084313 |
ChemSpider | 2341400 |
UNII | 5M64643B5U |
ChEBI | CHEBI:59925 |
ChEMBL | CHEMBL1378681 |
ECHA InfoCard | 100.039.157 |
Chemical and physical data | |
Formula | C32H43N5O5 |
Molar mass | 577.715 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References
This article is issued from Wikipedia - version of the 12/16/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.